Mark Slifka, Ph.D., pioneers new approach in vaccine development

YouTube Preview Image

Researchers at the Oregon National Primate Research Center have created a new vaccine development technique using a solution previously thought too damaging to be useful in vaccine production. Mark Slifka, Ph.D., and colleagues have successfully utilized hydrogen peroxide as a virus inactivator in the generation of three distinct vaccines. Vaccines for West Nile, Lymphocytic choriomeningitis, and vaccinia viruses have been created using this new technique, which supports the researchers’ claims that this could truly be a new platform technology in vaccine development.

Najít Technologies, an Oregon-based biotech company founded by Slifka and colleagues, has been working together with OHSU in the development of these vaccines and is confident that their findings, published online in the journal Nature Medicine, will help them to expand the commercial vaccine industry here in Portland.

Read the full article.

Bookmark and Share

Comments are closed.

About the Author

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.